248 related articles for article (PubMed ID: 29921614)
1. Peptidoglycan induces disseminated intravascular coagulation in baboons through activation of both coagulation pathways.
Popescu NI; Silasi R; Keshari RS; Girton A; Burgett T; Zeerleder SS; Gailani D; Gruber A; Lupu F; Coggeshall KM
Blood; 2018 Aug; 132(8):849-860. PubMed ID: 29921614
[TBL] [Abstract][Full Text] [Related]
2. Bacillus anthracis cell wall peptidoglycan but not lethal or edema toxins produces changes consistent with disseminated intravascular coagulation in a rat model.
Qiu P; Li Y; Shiloach J; Cui X; Sun J; Trinh L; Kubler-Kielb J; Vinogradov E; Mani H; Al-Hamad M; Fitz Y; Eichacker PQ
J Infect Dis; 2013 Sep; 208(6):978-89. PubMed ID: 23737601
[TBL] [Abstract][Full Text] [Related]
3. Complement C5 inhibition protects against hemolytic anemia and acute kidney injury in anthrax peptidoglycan-induced sepsis in baboons.
Keshari RS; Popescu NI; Silasi R; Regmi G; Lupu C; Simmons JH; Ricardo A; Coggeshall KM; Lupu F
Proc Natl Acad Sci U S A; 2021 Sep; 118(37):. PubMed ID: 34507997
[TBL] [Abstract][Full Text] [Related]
4. Monocyte procoagulant responses to anthrax peptidoglycan are reinforced by proinflammatory cytokine signaling.
Popescu NI; Girton A; Burgett T; Lovelady K; Coggeshall KM
Blood Adv; 2019 Aug; 3(16):2436-2447. PubMed ID: 31416821
[TBL] [Abstract][Full Text] [Related]
5. Factor XII Activation Promotes Platelet Consumption in the Presence of Bacterial-Type Long-Chain Polyphosphate In Vitro and In Vivo.
Zilberman-Rudenko J; Reitsma SE; Puy C; Rigg RA; Smith SA; Tucker EI; Silasi R; Merkulova A; McCrae KR; Maas C; Urbanus RT; Gailani D; Morrissey JH; Gruber A; Lupu F; Schmaier AH; McCarty OJT
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1748-1760. PubMed ID: 30354195
[TBL] [Abstract][Full Text] [Related]
6. Plasma bacterial and mitochondrial DNA distinguish bacterial sepsis from sterile systemic inflammatory response syndrome and quantify inflammatory tissue injury in nonhuman primates.
Sursal T; Stearns-Kurosawa DJ; Itagaki K; Oh SY; Sun S; Kurosawa S; Hauser CJ
Shock; 2013 Jan; 39(1):55-62. PubMed ID: 23247122
[TBL] [Abstract][Full Text] [Related]
7. Factor XII-mediated contact activation related to poor prognosis in disseminated intravascular coagulation.
Park HS; Gu J; You HJ; Kim JE; Kim HK
Thromb Res; 2016 Feb; 138():103-107. PubMed ID: 26706311
[TBL] [Abstract][Full Text] [Related]
8. Description of compensated and uncompensated disseminated intravascular coagulation (DIC) responses (non-overt and overt DIC) in baboon models of intravenous and intraperitoneal Escherichia coli sepsis and in the human model of endotoxemia: toward a better definition of DIC.
Taylor FB; Wada H; Kinasewitz G
Crit Care Med; 2000 Sep; 28(9 Suppl):S12-9. PubMed ID: 11007191
[TBL] [Abstract][Full Text] [Related]
9. Peptidoglycan from Bacillus anthracis Inhibits Human Macrophage Efferocytosis in Part by Reducing Cell Surface Expression of MERTK and TIM-3.
Mytych JS; Pan Z; Lopez-Davis C; Redinger N; Lawrence C; Ziegler J; Popescu NI; James JA; Farris AD
Immunohorizons; 2024 Mar; 8(3):269-280. PubMed ID: 38517345
[TBL] [Abstract][Full Text] [Related]
10. Crosstalk between the coagulation and complement systems in sepsis.
Lupu F; Keshari RS; Lambris JD; Coggeshall KM
Thromb Res; 2014 May; 133 Suppl 1(0 1):S28-31. PubMed ID: 24759136
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of contact-mediated activation of factor XI protects baboons against
Silasi R; Keshari RS; Lupu C; Van Rensburg WJ; Chaaban H; Regmi G; Shamanaev A; Shatzel JJ; Puy C; Lorentz CU; Tucker EI; Gailani D; Gruber A; McCarty OJT; Lupu F
Blood Adv; 2019 Feb; 3(4):658-669. PubMed ID: 30808684
[No Abstract] [Full Text] [Related]
12. Contact system activation in disseminated intravascular coagulation: activities of prekallikrein and high-molecular-weight kininogen are significant risk factors.
Park S; Gu JY; Kim HK
J Thromb Thrombolysis; 2022 Jul; 54(1):11-14. PubMed ID: 34993714
[TBL] [Abstract][Full Text] [Related]
13. A kallikrein-targeting RNA aptamer inhibits the intrinsic pathway of coagulation and reduces bradykinin release.
Steen Burrell KA; Layzer J; Sullenger BA
J Thromb Haemost; 2017 Sep; 15(9):1807-1817. PubMed ID: 28632925
[TBL] [Abstract][Full Text] [Related]
14. Management of cancer-associated disseminated intravascular coagulation.
Levi M
Thromb Res; 2016 Apr; 140 Suppl 1():S66-70. PubMed ID: 27067981
[TBL] [Abstract][Full Text] [Related]
15. Single-chain factor XII: a new form of activated factor XII.
Ivanov I; Matafonov A; Gailani D
Curr Opin Hematol; 2017 Sep; 24(5):411-418. PubMed ID: 28604413
[TBL] [Abstract][Full Text] [Related]
16. High-mobility group box 1 protein promotes development of microvascular thrombosis in rats.
Ito T; Kawahara K; Nakamura T; Yamada S; Nakamura T; Abeyama K; Hashiguchi T; Maruyama I
J Thromb Haemost; 2007 Jan; 5(1):109-16. PubMed ID: 17239166
[TBL] [Abstract][Full Text] [Related]
17. Possible involvement of cytokines in diffuse intravascular coagulation and thrombosis.
Esmon CT
Baillieres Best Pract Res Clin Haematol; 1999 Sep; 12(3):343-59. PubMed ID: 10856974
[TBL] [Abstract][Full Text] [Related]
18. Factor XII promotes blood coagulation independent of factor XI in the presence of long-chain polyphosphates.
Puy C; Tucker EI; Wong ZC; Gailani D; Smith SA; Choi SH; Morrissey JH; Gruber A; McCarty OJ
J Thromb Haemost; 2013 Jul; 11(7):1341-52. PubMed ID: 23659638
[TBL] [Abstract][Full Text] [Related]
19. Dual inhibition of thrombin and activated factor X attenuates disseminated intravascular coagulation and protects organ function in a baboon model of severe Gram-negative sepsis.
Schöchl H; van Griensven M; Heitmeier S; Laux V; Kipman U; Roodt J; Bahrami S; Redl H
Crit Care; 2017 Mar; 21(1):51. PubMed ID: 28288667
[TBL] [Abstract][Full Text] [Related]
20. Factor XII as a Therapeutic Target in Thromboembolic and Inflammatory Diseases.
Nickel KF; Long AT; Fuchs TA; Butler LM; Renné T
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):13-20. PubMed ID: 27834692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
